Last $3.52 USD
Change Today +0.0299 / 0.86%
Volume 341.0
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

chembio diagnostics inc (CEMI) Snapshot

Open
$3.64
Previous Close
$3.49
Day High
$3.64
Day Low
$3.52
52 Week High
09/19/13 - $4.13
52 Week Low
05/8/14 - $2.83
Market Cap
33.8M
Average Volume 10 Days
46.9K
EPS TTM
--
Shares Outstanding
9.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHEMBIO DIAGNOSTICS INC (CEMI)

Related News

No related news articles were found.

chembio diagnostics inc (CEMI) Related Businessweek News

No Related Businessweek News Found

chembio diagnostics inc (CEMI) Details

Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The company’s products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a Syphilis multiplex test for the detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies and antigens. Chembio Diagnostics, Inc. sells its products under STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology products. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.

chembio diagnostics inc (CEMI) Top Compensated Officers

Chief Operating Officer
Total Annual Compensation: $239.6K
Senior Vice President of Research & Developme...
Total Annual Compensation: $337.1K
Vice President of Regulatory Affairs, Quality...
Total Annual Compensation: $229.8K
Compensation as of Fiscal Year 2013.

chembio diagnostics inc (CEMI) Key Developments

Chembio Diagnostics, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Chembio Diagnostics, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, total revenues were $7,422,597,000 against $5,393,522,000 a year ago. Loss from operations was $232,865,000 against $379,726,000 a year ago. Net loss was $145,981,000 or $0.02 per basic and diluted share against $240,989,000 or $0.03 per basic and diluted share a year ago. For the six months, total revenues were $13,235,670,000 against $12,071,675,000 a year ago. Loss from operations was $615,604,000 against income from operations of $106,825,000 a year ago. Net income was $370,720,000 or $0.04 per basic and diluted share against net income of $76,135,000 or $0.01 per basic and diluted share a year ago. Net cash used in operating activities was $2,535,529,000 against net cash provided by operating activities of $802,771,000 a year ago.

Chembio Diagnostics, Inc. to Report Q2, 2014 Results on Aug 07, 2014

Chembio Diagnostics, Inc. announced that they will report Q2, 2014 results at 9:00 AM, Eastern Standard Time on Aug 07, 2014

Chembio Diagnostics, Inc., Q2 2014 Earnings Call, Aug 07, 2014

Chembio Diagnostics, Inc., Q2 2014 Earnings Call, Aug 07, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CEMI:US $3.52 USD +0.0299

CEMI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $34.81 USD -0.20
OraSure Technologies Inc $7.78 USD -0.05
Trinity Biotech PLC $20.98 USD -0.09
View Industry Companies
 

Industry Analysis

CEMI

Industry Average

Valuation CEMI Industry Range
No financial data is available for CEMI.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMBIO DIAGNOSTICS INC, please visit www.chembio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.